Publication: Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy
Issued Date
2013-10-01
Resource Type
ISSN
18783511
12019712
12019712
Other identifier(s)
2-s2.0-84883783112
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Infectious Diseases. Vol.17, No.10 (2013)
Suggested Citation
Torsak Bunupuradah, Azar Kariminia, Kwai Cheng Chan, Reshmie Ramautarsing, Bui Vu Huy, Ning Han, Revathy Nallusamy, Rawiwan Hansudewechakul, Vonthanak Saphonn, Virat Sirisanthana, Kulkanya Chokephaibulkit, Nia Kurniati, Nagalingeswaran Kumarasamy, Nik Khairulddin Nik Yusoff, Kamarul Razali, Siew Moy Fong, Annette H. Sohn, Pagakrong Lumbiganon Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy. International Journal of Infectious Diseases. Vol.17, No.10 (2013). doi:10.1016/j.ijid.2013.04.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/32150
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy
Author(s)
Torsak Bunupuradah
Azar Kariminia
Kwai Cheng Chan
Reshmie Ramautarsing
Bui Vu Huy
Ning Han
Revathy Nallusamy
Rawiwan Hansudewechakul
Vonthanak Saphonn
Virat Sirisanthana
Kulkanya Chokephaibulkit
Nia Kurniati
Nagalingeswaran Kumarasamy
Nik Khairulddin Nik Yusoff
Kamarul Razali
Siew Moy Fong
Annette H. Sohn
Pagakrong Lumbiganon
Azar Kariminia
Kwai Cheng Chan
Reshmie Ramautarsing
Bui Vu Huy
Ning Han
Revathy Nallusamy
Rawiwan Hansudewechakul
Vonthanak Saphonn
Virat Sirisanthana
Kulkanya Chokephaibulkit
Nia Kurniati
Nagalingeswaran Kumarasamy
Nik Khairulddin Nik Yusoff
Kamarul Razali
Siew Moy Fong
Annette H. Sohn
Pagakrong Lumbiganon
Other Contributor(s)
The HIV Netherlands Australia Thailand Research Collaboration
University of New South Wales (UNSW) Australia
Hospital Pulau Pinang
Academic Medical Centre, University of Amsterdam
National Hospital of Pediatrics Hanoi
Beijing Ditan Hospital
Chiangrai Prachanukroh Hospital
National Pediatric Hospital
Chiang Mai University
Mahidol University
University of Indonesia, RSUPN Dr. Cipto Mangunkusumo
YR Gaitonde Centre for AIDS Research and Education
Hospital Raja Perempuan Zainab II
Kuala Lumpur Hospital
Hospital Likas
TREAT Asia/amfAR-The Foundation for AIDS Research
Khon Kaen University
University of New South Wales (UNSW) Australia
Hospital Pulau Pinang
Academic Medical Centre, University of Amsterdam
National Hospital of Pediatrics Hanoi
Beijing Ditan Hospital
Chiangrai Prachanukroh Hospital
National Pediatric Hospital
Chiang Mai University
Mahidol University
University of Indonesia, RSUPN Dr. Cipto Mangunkusumo
YR Gaitonde Centre for AIDS Research and Education
Hospital Raja Perempuan Zainab II
Kuala Lumpur Hospital
Hospital Likas
TREAT Asia/amfAR-The Foundation for AIDS Research
Khon Kaen University
Abstract
Background: There are limited data on treatment-related anemia in Asian HIV-infected children. Methods: Data from Asian HIV-infected children aged <18 years on first-line highly active antiretroviral therapy (HAART) were used. Children who had pre-existing severe anemia at baseline were excluded. Anemia was graded using the United States Division of AIDS (DAIDS) 2004 table. Potential risk factors for severe anemia were assessed by logistic regression. Results: Data from 1648 children (51.9% female, 62.8% World Health Organization (WHO) stage 3/4) were analyzed. Median (interquartile range) age was 6.8 (3.7-9.6) years, CD4% was 9 (3-16)%, and plasma HIV-RNA was 5.2 (4.7-5.6) log10copies/ml at HAART initiation in those with available testing. The most common regimens were stavudine/lamivudine/nevirapine (42%) and zidovudine/lamivudine/nevirapine (25%). Severe anemia was identified in 47 (2.9%) children after a median time of 6 months after HAART initiation, with an incidence rate of 5.4 per 100 child-years. Mild anemia or moderate anemia at baseline (p = 0.024 and p = 0.005, respectively), previous or current use of zidovudine (p < 0.0001 and p = 0.013, respectively), and male sex (p = 0.008) were associated with severe anemia. Higher weight-for-age z-score (p = 0.004) was protective. Conclusions: The incidence of severe anemia in Asian HIV-infected children after HAART initiation was low and mainly occurred during the first few months after HAART initiation. Mild to moderate anemia at baseline and using zidovudine were independent risk factors for the development of severe anemia. © 2013 International Society for Infectious Diseases.